HEPATITIS A EPIDEMIOLOGY, HIGH-RISK GROUPS AND PREVENTIVE MEASURES
(LITERATURE REVIEW)

B.M. Mamatkulov; A.A. Nematov; D.A. Berdimuratov; G.K. Tolipova

doi:10.5281/zenodo.7952309

HEPATITIS A EPIDEMIOLOGY, HIGH-RISK GROUPS AND PREVENTIVE MEASURES (LITERATURE REVIEW)

20.05.2023 International Scientific Journal "Science and Innovation". Series D. Volume 2 Issue 5

B.M. Mamatkulov, A.A. Nematov, D.A. Berdimuratov, G.K. Tolipova

Abstract. Viral hepatitis A (VHA) is the main cause of acute viral hepatitis worldwide. It is mainly transmitted by direct contact with infected patients or by consuming contaminated water or food. The virus is endemic in low-income countries with poor sanitary and socio-demographic conditions. This article lists data on the epidemiology, prevalence, risk factors, vaccination and prevention of hepatitis A.

Keywords: Hepatitis A, epidemiology, risk groups, vaccination, preventive measures

References:

1. Lemon S.M., Ott J.J., Van Damme P., Shouval D. Type A Viral Hepatitis: A Summary and Update on the Molecular Virology, Epidemiology, Pathogenesis and Prevention. J. Hepatol. 2018;68:167–184. doi: 10.1016/j.jhep.2017.08.034. 2. World Health Organization . WHO Immunological Basis for Immunization Series, Module 18: Hepatitis A Update. WHO; Geneva, Switzerland: 2019. 3. Nelson N.P., Weng M.K., Hofmeister M.G., Moore K.L., Doshani M., Kamili S., Koneru A., Haber P., Hagan L., Romero J.R., et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm. Rep. 2020;69:1–38. doi: 10.15585/mmwr.rr6905a1. 4. Siegl G., Weitz M., Kronauer G. Stability of Hepatitis A Virus. Intervirology. 1984;22:218–226. doi: 10.1159/000149554. 5. Ramsay C.N., Upton P.A. Hepatitis A and Frozen Raspberries. Lancet. 1989;1:43–44. doi: 10.1016/S0140-6736(89)91698-X. 6. McCaustland K.A., Bond W.W., Bradley D.W., Ebert J.W., Maynard J.E. Survival of Hepatitis A Virus in Feces after Drying and Storage for 1 Month. J. Clin. Microbiol. 1982;16:957–958. doi: 10.1128/jcm.16.5.957-958.1982. 7. Costafreda M.I., Pérez-Rodriguez F.J., D’Andrea L., Guix S., Ribes E., Bosch A., Pintó R.M. Hepatitis A Virus Adaptation to Cellular Shutoff Is Driven by Dynamic Adjustments of Codon Usage and Results in the Selection of Populations with Altered Capsids. J. Virol. 2014;88:5029–5041. doi: 10.1128/JVI.00087-14. 8. Tjon G.M.S., Coutinho R.A., van den Hoek A., Esman S., Wijkmans C.J., Hoebe C.J.P.A., Wolters B., Swaan C., Geskus R.B., Dukers N., et al. High and Persistent Excretion of Hepatitis A Virus in Immunocompetent Patients. J. Med. Virol. 2006;78:1398–1405. doi: 10.1002/jmv.20711. 9. Severi E., Verhoef L., Thornton L., Guzman-Herrador B.R., Faber M., Sundqvist L., Rimhanen-Finne R., Roque-Afonso A.M., Ngui S.L., Allerberger F., et al. Large and Prolonged Food-Borne Multistate Hepatitis A Outbreak in Europe Associated with Consumption of Frozen Berries, 2013 to 2014. Euro Surveill. 2015;20:21192. doi: 10.2807/1560-7917.ES2015.20.29.21192. 10. Garcia Vilaplana T., Leeman D., Balogun K., Ngui S.L., Phipps E., Khan W.M., Incident Team. Balasegaram S. Hepatitis A Outbreak Associated with Consumption of Dates, England and Wales, January 2021 to April 2021. Euro Surveill. 2021;26:2100432. doi: 10.2807/1560-7917.ES.2021.26.20.2100432. 11. Halliday M.L., Kang L.-Y., Zhou T.-K., Hu M.-D., Pan Q.-C., Fu T.-Y., Huang Y.-S., Hu S.-L. An Epidemic of Hepatitis A Attributable to the Ingestion of Raw Clams in Shanghai, China. J. Infect. Dis. 1991;164:852–859. doi: 10.1093/infdis/164.5.852. 12. Pintó R.M., Costafreda M.I., Bosch A. Risk Assessment in Shellfish-Borne Outbreaks of Hepatitis A. Appl. Environ. Microbiol. 2009;75:7350–7355. doi: 10.1128/AEM.01177-09. 13. Di Cola G., Fantilli A.C., Pisano M.B., Ré V.E. Foodborne Transmission of Hepatitis A and Hepatitis E Viruses: A Literature Review. Int. J. Food Microbiol. 2021;338:108986. doi: 10.1016/j.ijfoodmicro.2020.108986. 14. Foster M.A., Weil L.M., Jin S., Johnson T., Hayden-Mixson T.R., Khudyakov Y., Annambhotla P.D., Basavaraju S.V., Kamili S., Ritter J.M., et al. Transmission of Hepatitis A Virus through Combined Liver-Small Intestine-Pancreas Transplantation. Emerg. Infect. Dis. 2017;23:590–596. doi: 10.3201/eid2304.161532. 15. Zeng D.-Y., Li J.-M., Lin S., Dong X., You J., Xing Q.-Q., Ren Y.-D., Chen W.-M., Cai Y.-Y., Fang K., et al. Global Burden of Acute Viral Hepatitis and Its Association with Socioeconomic Development Status, 1990–2019. J. Hepatol. 2021:S0168827821003007. doi: 10.1016/j.jhep.2021.04.035. 16. Jacobsen K.H. Globalization and the Changing Epidemiology of Hepatitis A Virus. Cold Spring Harb. Perspect. Med. 2018;8:a031716. doi: 10.1101/cshperspect.a031716. 17. Thüring EG, J.-J. H., Sareth H, Sokhan U, Reth C, Grob P. Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province. Southeast Asian J. Trop. Med. Public. Health24(2), 11 (1993). 18. World Health Organization . WHO Immunological Basis for Immunization Series, Module 18: Hepatitis A Update. WHO; Geneva, Switzerland: 2019. 19. Werzberger A., Mensch B., Kuter B., Brown L., Lewis J., Sitrin R., Miller W., Shouval D., Wiens B., Calandra G. A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children. N. Engl. J. Med. 1992;327:453–457. doi: 10.1056/NEJM199208133270702. 20. Mao J.S., Dong D.X., Zhang H.Y., Chen N.L., Zhang X.Y., Huang H.Y., Xie R.Y., Zhou T.J., Wan Z.J., Wang Y.Z. Primary Study of Attenuated Live Hepatitis A Vaccine (H2 Strain) in Humans. J. Infect. Dis. 1989;159:621–624. doi: 10.1093/infdis/159.4.621. 21. Victor J.C., Monto A.S., Surdina T.Y., Suleimenova S.Z., Vaughan G., Nainan O.V., Favorov M.O., Margolis H.S., Bell B.P. Hepatitis A Vaccine versus Immune Globulin for Postexposure Prophylaxis. N. Engl. J. Med. 2007;357:1685–1694. doi: 10.1056/NEJMoa070546. 22. Shouval D. Immunization against Hepatitis A. Cold Spring Harb. Perspect. Med. 2019;9:a031682. doi: 10.1101/cshperspect.a031682. 23. Nelson N.P., Link-Gelles R., Hofmeister M.G., Romero J.R., Moore K.L., Ward J.W., Schillie S.F. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel. MMWR Morb. Mortal. Wkly. Rep. 2018;67:1216–1220. doi: 10.15585/mmwr.mm6743a5. 24. Ojeda-Martinez H.I., McGowan J.P., Fine S.M., Vail R., Merrick S.T., Radix A., Hoffmann C.J., Gonzalez C.J. Prevention and Management of Hepatitis A Virus in Adults With HIV. Johns Hopkins University; Baltimore, MD, USA: 2021. New York State Department of Health AIDS Institute Clinical Guidelines. 25. Stuurman A.L., Marano C., Bunge E.M., De Moerlooze L., Shouval D. Impact of Universal Mass Vaccination with Monovalent Inactivated Hepatitis A Vaccines—A Systematic Review. Hum. Vaccin. Immunother. 2017;13:724–736. doi: 10.1080/21645515.2016.1242539. 26. D’Andrea L., Pérez-Rodríguez F.J., de Castellarnau M., Manzanares S., Lite J., Guix S., Bosch A., Pintó R.M. Hepatitis A Virus Genotype Distribution during a Decade of Universal Vaccination of Preadolescents. Int. J. Mol. Sci. 2015;16:6842–6854. doi: 10.3390/ijms16046842. 27. Andani A., van Damme P., Bunge E.M., Salgado F., van Hoorn R.C., Hoet B. One or Two Doses of Hepatitis A Vaccine in Universal Vaccination Programs in Children in 2020: A Systematic Review. Vaccine. 2021;29:S0264410X21000542. doi: 10.1016/j.vaccine.2021.01.038. 28. Vizzotti C., González J., Gentile A., Rearte A., Ramonet M., Cañero-Velasco M.C., Pérez Carrega M.E., Urueña A., Diosque M. Impact of the Single-Dose Immunization Strategy Against Hepatitis A in Argentina. Pediatr. Infect. Dis. J. 2014;33:84–88. doi: 10.1097/INF.0000000000000042. 29. Sabrià A., Gregori J., Garcia-Cehic D., Guix S., Pumarola T., Manzanares-Laya S., Caylà J.A., Bosch A., Quer J., Pintó R.M. Evidence for Positive Selection of Hepatitis A Virus Antigenic Variants in Vaccinated Men-VGAing-Sex-with Men Patients: Implications for Immunization Policies. EBio Med. 2018;39:348–357. doi: 10.1016/j.ebiom.2018.11.023. 30. Tapia-Conyer R, Santos JI, Cavalcanti AM, Urdaneta E, Rivera L, Manterola A, Potin M, Ruttiman R, Tanaka Kido J. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg. 1999 Nov;61(5):825–829. doi: 10.4269/ajtmh.1999.61.825. 31. Толипова Г. К., Маматмусаева Ф. Ш. ВИРУСЛИ ГЕПАТИТ А ЎТКАЗГАН РЕКОНВАЛЕСЦЕНТ БОЛАЛАРДА РЕКОНВАЛЕСЦЕНЦИЯ МУДДАТЛАРИГА БОҒЛИҚ РАВИШДА КЛИНИК БЕЛГИЛАРНИНГ ЎЗГАРИШИ : дис. – 2022. 32. Маматмусаева, ГК Толипова ФШ. "МИКРОСКОПИЧЕСКИЙ СОСТАВ ЖЕЛЧИ У ДЕТЕЙ ВИРУСНЫХ ГЕПАТИТАХ «А»,«В» и «С»." (2022). 33. Tolipova G. K., Mamatmusayeva F. S. MOTORIC FUNCTION OF THE BILIARY SYSTEM AT CHILDREN CONVALESCENTIA VIRAL HEPATITIS" A" AND" B" AND THEIR CORRECTION //INNOVATIVE DEVELOPMENT IN THE GLOBAL SCIENCE. – 2022. – Т. 1. – №. 6. – С. 32-36. 34. Халилова Б. Р., Мусаева О. Т., Толипова Г. К. ВЛИЯНИЕ ОДОНТОГЕННОЙ ИНФЕКЦИИ НА OРГАНИЗМ БЕРЕМЕННЫХ ЖЕНЩИНЫ //Scientific progress. – 2023. – Т. 4. – №. 2. – С. 245-251. 35. Mamatkulov, B., Tolipova, G., Adilova, Z., & Nematov, A. (2023). ПРОБЛЕМЫ ИММУНОПРОФИЛАКТИКИ: ФАКТОРЫ ВЛИЯНИЕ НА ФОРМИРОВАНИЕ ОТНОШЕНИЯ К ИММУНОПРОФИЛАКТИКЕ. 36. Mamatkulov B. M., Nematov A. A., Bakhora V. U. The Role of Social-Hygienic and Medical-Biological Factors in the Spread of Coronavirus Infection (SARS-CoV-2) Among the Population //American Journal of Medicine and Medical Sciences. – 2022. – Т. 12. – №. 9. – С. 943-947. 37. Mamatkulov, B., Urazaliyeva, I., Tolipova, G., & Musayeva, O. (2023). The Significance of Factors in Forming Attitude to Immunophrophylaxis and the Problems of Immunophrophylaxis. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 2(4), 7-14. 38. Тураев Б. Ш., Авезова Г. С. МЕДИКО-БИОЛОГИЧЕСКИЕ И СОЦИАЛЬНО-ГИГИЕНИЧЕСКИЕ ХАРАКТЕРИСТИКИ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ МУЖЧИН //Young scientists' and mentors' non-standart congress. – 2017. – С. 192-196. 39. Masharipova, R., Togaynazarov, S., Pakhrudinova, N., Khasanova, G., & Abdurahimov, B. (2020). The main factors of formation and physical culture in society. Systematic Reviews in Pharmacy, 11(12). 40. Абдурахимов, Б., Хайитов, Ж., Сафаров, Х., & Улмасов, Ж. (2023). ОСОБЕННОСТИ ЗАБОЛЕВАЕМОСТИ РАБОТНИКОВ ПРЕДПРИЯТИЙ МЕДНОЙ ПРОМЫШЛЕННОСТИ.